APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyurea Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hydroxyurea Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174000840328 December 2025197 pages

Choose your research edition.

Industry ResearchHydroxyurea Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyurea Tablets Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Hydroxyurea Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyurea Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyurea Tablets Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Hydroxyurea Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hydroxyurea Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydroxyurea Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxyurea Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hydroxyurea Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydroxyurea Tablets include Bristol Myers Squibb, EVATIS, Medunik USA, TAJ Pharma, Anguo Yadong Biopharmaceutical, Beijing Jialin Pharmaceutical, Beijing Yanjing Pharmaceutical, Guangxi Nanning Baihui Pharmaceutical and Sinopharm Group Zhonglian Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydroxyurea Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydroxyurea Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxyurea Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxyurea Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxyurea Tablets Segment by Company

Bristol Myers Squibb

EVATIS

Medunik USA

TAJ Pharma

Anguo Yadong Biopharmaceutical

Beijing Jialin Pharmaceutical

Beijing Yanjing Pharmaceutical

Guangxi Nanning Baihui Pharmaceutical

Sinopharm Group Zhonglian Pharmaceutical

Qilu Pharmaceutical

Shandong Anxin Pharmaceutical

Shanxi Zhendong Anxin Biopharmaceutical

Hydroxyurea Tablets Segment by Type

0.25g

0.5g

Hydroxyurea Tablets Segment by Application

Hospital

Clinic

Hydroxyurea Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyurea Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyurea Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyurea Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxyurea Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxyurea Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydroxyurea Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydroxyurea Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydroxyurea Tablets Industry Trends Table 2. Hydroxyurea Tablets Industry Drivers Table 3. Hydroxyurea Tablets Industry Opportunities and Challenges Table 4. Hydroxyurea Tablets Industry Restraints Table 5. Global Hydroxyurea Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydroxyurea Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydroxyurea Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hydroxyurea Tablets Sales Market Share by Manufacturers Table 9. Global Hydroxyurea Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hydroxyurea Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydroxyurea Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydroxyurea Tablets Manufacturers, Product Type & Application Table 13. Global Hydroxyurea Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxyurea Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.25g Table 17. Major Manufacturers of 0.5g Table 18. Global Hydroxyurea Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Hydroxyurea Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Hydroxyurea Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Hydroxyurea Tablets Sales Market Share by Type (2021-2026) Table 22. Global Hydroxyurea Tablets Sales Market Share by Type (2027-2032) Table 23. Global Hydroxyurea Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Hydroxyurea Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Hydroxyurea Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Hydroxyurea Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Hydroxyurea Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Hydroxyurea Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Hydroxyurea Tablets Sales by Application (2021-2026) & (K Units) Table 32. Global Hydroxyurea Tablets Sales by Application (2027-2032) & (K Units) Table 33. Global Hydroxyurea Tablets Sales Market Share by Application (2021-2026) Table 34. Global Hydroxyurea Tablets Sales Market Share by Application (2027-2032) Table 35. Global Hydroxyurea Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Hydroxyurea Tablets Revenue by Application (2021-2026) & (K Units) Table 37. Global Hydroxyurea Tablets Revenue by Application (2027-2032) & (K Units) Table 38. Global Hydroxyurea Tablets Revenue Market Share by Application (2021-2026) Table 39. Global Hydroxyurea Tablets Revenue Market Share by Application (2027-2032) Table 40. Global Hydroxyurea Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Hydroxyurea Tablets Sales by Region (2021-2026) & (K Units) Table 42. Global Hydroxyurea Tablets Sales Market Share by Region (2021-2026) Table 43. Global Hydroxyurea Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Hydroxyurea Tablets Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hydroxyurea Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Hydroxyurea Tablets Sales by Country (2021-2026) & (K Units) Table 47. North America Hydroxyurea Tablets Sales by Country (2027-2032) & (K Units) Table 48. Europe Hydroxyurea Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Hydroxyurea Tablets Sales by Country (2021-2026) & (K Units) Table 50. Europe Hydroxyurea Tablets Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Hydroxyurea Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Hydroxyurea Tablets Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Hydroxyurea Tablets Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Hydroxyurea Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Hydroxyurea Tablets Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Hydroxyurea Tablets Sales by Country (2027-2032) & (K Units) Table 57. Global Hydroxyurea Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hydroxyurea Tablets Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hydroxyurea Tablets Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hydroxyurea Tablets Revenue Market Share by Region (2021-2026) Table 61. Global Hydroxyurea Tablets Revenue Market Share by Region (2027-2032) Table 62. Bristol Myers Squibb Company Information Table 63. Bristol Myers Squibb Business Overview Table 64. Bristol Myers Squibb Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Bristol Myers Squibb Hydroxyurea Tablets Product Portfolio Table 66. Bristol Myers Squibb Recent Development Table 67. EVATIS Company Information Table 68. EVATIS Business Overview Table 69. EVATIS Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. EVATIS Hydroxyurea Tablets Product Portfolio Table 71. EVATIS Recent Development Table 72. Medunik USA Company Information Table 73. Medunik USA Business Overview Table 74. Medunik USA Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Medunik USA Hydroxyurea Tablets Product Portfolio Table 76. Medunik USA Recent Development Table 77. TAJ Pharma Company Information Table 78. TAJ Pharma Business Overview Table 79. TAJ Pharma Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. TAJ Pharma Hydroxyurea Tablets Product Portfolio Table 81. TAJ Pharma Recent Development Table 82. Anguo Yadong Biopharmaceutical Company Information Table 83. Anguo Yadong Biopharmaceutical Business Overview Table 84. Anguo Yadong Biopharmaceutical Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Anguo Yadong Biopharmaceutical Hydroxyurea Tablets Product Portfolio Table 86. Anguo Yadong Biopharmaceutical Recent Development Table 87. Beijing Jialin Pharmaceutical Company Information Table 88. Beijing Jialin Pharmaceutical Business Overview Table 89. Beijing Jialin Pharmaceutical Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Beijing Jialin Pharmaceutical Hydroxyurea Tablets Product Portfolio Table 91. Beijing Jialin Pharmaceutical Recent Development Table 92. Beijing Yanjing Pharmaceutical Company Information Table 93. Beijing Yanjing Pharmaceutical Business Overview Table 94. Beijing Yanjing Pharmaceutical Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Beijing Yanjing Pharmaceutical Hydroxyurea Tablets Product Portfolio Table 96. Beijing Yanjing Pharmaceutical Recent Development Table 97. Guangxi Nanning Baihui Pharmaceutical Company Information Table 98. Guangxi Nanning Baihui Pharmaceutical Business Overview Table 99. Guangxi Nanning Baihui Pharmaceutical Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Guangxi Nanning Baihui Pharmaceutical Hydroxyurea Tablets Product Portfolio Table 101. Guangxi Nanning Baihui Pharmaceutical Recent Development Table 102. Sinopharm Group Zhonglian Pharmaceutical Company Information Table 103. Sinopharm Group Zhonglian Pharmaceutical Business Overview Table 104. Sinopharm Group Zhonglian Pharmaceutical Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Sinopharm Group Zhonglian Pharmaceutical Hydroxyurea Tablets Product Portfolio Table 106. Sinopharm Group Zhonglian Pharmaceutical Recent Development Table 107. Qilu Pharmaceutical Company Information Table 108. Qilu Pharmaceutical Business Overview Table 109. Qilu Pharmaceutical Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Qilu Pharmaceutical Hydroxyurea Tablets Product Portfolio Table 111. Qilu Pharmaceutical Recent Development Table 112. Shandong Anxin Pharmaceutical Company Information Table 113. Shandong Anxin Pharmaceutical Business Overview Table 114. Shandong Anxin Pharmaceutical Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Shandong Anxin Pharmaceutical Hydroxyurea Tablets Product Portfolio Table 116. Shandong Anxin Pharmaceutical Recent Development Table 117. Shanxi Zhendong Anxin Biopharmaceutical Company Information Table 118. Shanxi Zhendong Anxin Biopharmaceutical Business Overview Table 119. Shanxi Zhendong Anxin Biopharmaceutical Hydroxyurea Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Shanxi Zhendong Anxin Biopharmaceutical Hydroxyurea Tablets Product Portfolio Table 121. Shanxi Zhendong Anxin Biopharmaceutical Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Hydroxyurea Tablets Distributors List Table 125. Hydroxyurea Tablets Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Hydroxyurea Tablets Product Image Figure 2. Global Hydroxyurea Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyurea Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxyurea Tablets Sales (2021-2032) & (K Units) Figure 5. Global Hydroxyurea Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hydroxyurea Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.25g Image Figure 9. 0.5g Image Figure 10. Global Hydroxyurea Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Hydroxyurea Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hydroxyurea Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Hydroxyurea Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hydroxyurea Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hydroxyurea Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Hydroxyurea Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Hydroxyurea Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hydroxyurea Tablets Sales Market Share by Application (2021-2032) Figure 21. Global Hydroxyurea Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Hydroxyurea Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hydroxyurea Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Hydroxyurea Tablets Sales Market Share by Country (2021-2032) Figure 26. U.S. Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Hydroxyurea Tablets Sales Market Share by Country (2021-2032) Figure 31. Germany Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Hydroxyurea Tablets Sales Market Share by Country (2021-2032) Figure 38. China Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Hydroxyurea Tablets Sales Market Share by Country (2021-2032) Figure 46. Brazil Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Hydroxyurea Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Hydroxyurea Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hydroxyurea Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hydroxyurea Tablets Revenue (2021-2032) & (US$ Million) Figure 57. North America Hydroxyurea Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hydroxyurea Tablets Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hydroxyurea Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hydroxyurea Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hydroxyurea Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hydroxyurea Tablets Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hydroxyurea Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hydroxyurea Tablets Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hydroxyurea Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g
  • 0.5g
Applications
  • Hospital
  • Clinic
Companies covered
  • Bristol Myers Squibb
  • EVATIS
  • Medunik USA
  • TAJ Pharma
  • Anguo Yadong Biopharmaceutical
  • Beijing Jialin Pharmaceutical
  • Beijing Yanjing Pharmaceutical
  • Guangxi Nanning Baihui Pharmaceutical
  • Sinopharm Group Zhonglian Pharmaceutical
  • Qilu Pharmaceutical
  • Shandong Anxin Pharmaceutical
  • Shanxi Zhendong Anxin Biopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydroxyurea Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydroxyurea Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydroxyurea Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydroxyurea Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydroxyurea Tablets Market Dynamics
  1. 2.1 Hydroxyurea Tablets Industry Trends
  2. 2.2 Hydroxyurea Tablets Industry Drivers
  3. 2.3 Hydroxyurea Tablets Industry Opportunities and Challenges
  4. 2.4 Hydroxyurea Tablets Industry Restraints
3 Hydroxyurea Tablets Market by Manufacturers
  1. 3.1 Global Hydroxyurea Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydroxyurea Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydroxyurea Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydroxyurea Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxyurea Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydroxyurea Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Hydroxyurea Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxyurea Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxyurea Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxyurea Tablets Tier 1, Tier 2, and Tier 3
4 Hydroxyurea Tablets Market by Type
  1. 4.1 Hydroxyurea Tablets Type Introduction
  2. 4.1.1 0.25g
  3. 4.1.2 0.5g
  4. 4.2 Global Hydroxyurea Tablets Sales by Type
  5. 4.2.1 Global Hydroxyurea Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hydroxyurea Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Hydroxyurea Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hydroxyurea Tablets Revenue by Type
  9. 4.3.1 Global Hydroxyurea Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hydroxyurea Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Hydroxyurea Tablets Revenue Market Share by Type (2021-2032)
5 Hydroxyurea Tablets Market by Application
  1. 5.1 Hydroxyurea Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Hydroxyurea Tablets Sales by Application
  5. 5.2.1 Global Hydroxyurea Tablets Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydroxyurea Tablets Sales by Application (2021-2032)
  7. 5.2.3 Global Hydroxyurea Tablets Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hydroxyurea Tablets Revenue by Application
  9. 5.3.1 Global Hydroxyurea Tablets Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydroxyurea Tablets Revenue by Application (2021-2032)
  11. 5.3.3 Global Hydroxyurea Tablets Revenue Market Share by Application (2021-2032)
6 Global Hydroxyurea Tablets Sales by Region
  1. 6.1 Global Hydroxyurea Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxyurea Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxyurea Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Hydroxyurea Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydroxyurea Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydroxyurea Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydroxyurea Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydroxyurea Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydroxyurea Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydroxyurea Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydroxyurea Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydroxyurea Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydroxyurea Tablets Revenue by Region
  1. 7.1 Global Hydroxyurea Tablets Revenue by Region
  2. 7.1.1 Global Hydroxyurea Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydroxyurea Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydroxyurea Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydroxyurea Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydroxyurea Tablets Revenue (2021-2032)
  8. 7.2.2 North America Hydroxyurea Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydroxyurea Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Hydroxyurea Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydroxyurea Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydroxyurea Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydroxyurea Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydroxyurea Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bristol Myers Squibb
  2. 8.1.1 Bristol Myers Squibb Company Information
  3. 8.1.2 Bristol Myers Squibb Business Overview
  4. 8.1.3 Bristol Myers Squibb Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bristol Myers Squibb Hydroxyurea Tablets Product Portfolio
  6. 8.1.5 Bristol Myers Squibb Recent Developments
  7. 8.2 EVATIS
  8. 8.2.1 EVATIS Company Information
  9. 8.2.2 EVATIS Business Overview
  10. 8.2.3 EVATIS Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 EVATIS Hydroxyurea Tablets Product Portfolio
  12. 8.2.5 EVATIS Recent Developments
  13. 8.3 Medunik USA
  14. 8.3.1 Medunik USA Company Information
  15. 8.3.2 Medunik USA Business Overview
  16. 8.3.3 Medunik USA Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medunik USA Hydroxyurea Tablets Product Portfolio
  18. 8.3.5 Medunik USA Recent Developments
  19. 8.4 TAJ Pharma
  20. 8.4.1 TAJ Pharma Company Information
  21. 8.4.2 TAJ Pharma Business Overview
  22. 8.4.3 TAJ Pharma Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TAJ Pharma Hydroxyurea Tablets Product Portfolio
  24. 8.4.5 TAJ Pharma Recent Developments
  25. 8.5 Anguo Yadong Biopharmaceutical
  26. 8.5.1 Anguo Yadong Biopharmaceutical Company Information
  27. 8.5.2 Anguo Yadong Biopharmaceutical Business Overview
  28. 8.5.3 Anguo Yadong Biopharmaceutical Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Anguo Yadong Biopharmaceutical Hydroxyurea Tablets Product Portfolio
  30. 8.5.5 Anguo Yadong Biopharmaceutical Recent Developments
  31. 8.6 Beijing Jialin Pharmaceutical
  32. 8.6.1 Beijing Jialin Pharmaceutical Company Information
  33. 8.6.2 Beijing Jialin Pharmaceutical Business Overview
  34. 8.6.3 Beijing Jialin Pharmaceutical Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Jialin Pharmaceutical Hydroxyurea Tablets Product Portfolio
  36. 8.6.5 Beijing Jialin Pharmaceutical Recent Developments
  37. 8.7 Beijing Yanjing Pharmaceutical
  38. 8.7.1 Beijing Yanjing Pharmaceutical Company Information
  39. 8.7.2 Beijing Yanjing Pharmaceutical Business Overview
  40. 8.7.3 Beijing Yanjing Pharmaceutical Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Yanjing Pharmaceutical Hydroxyurea Tablets Product Portfolio
  42. 8.7.5 Beijing Yanjing Pharmaceutical Recent Developments
  43. 8.8 Guangxi Nanning Baihui Pharmaceutical
  44. 8.8.1 Guangxi Nanning Baihui Pharmaceutical Company Information
  45. 8.8.2 Guangxi Nanning Baihui Pharmaceutical Business Overview
  46. 8.8.3 Guangxi Nanning Baihui Pharmaceutical Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guangxi Nanning Baihui Pharmaceutical Hydroxyurea Tablets Product Portfolio
  48. 8.8.5 Guangxi Nanning Baihui Pharmaceutical Recent Developments
  49. 8.9 Sinopharm Group Zhonglian Pharmaceutical
  50. 8.9.1 Sinopharm Group Zhonglian Pharmaceutical Company Information
  51. 8.9.2 Sinopharm Group Zhonglian Pharmaceutical Business Overview
  52. 8.9.3 Sinopharm Group Zhonglian Pharmaceutical Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sinopharm Group Zhonglian Pharmaceutical Hydroxyurea Tablets Product Portfolio
  54. 8.9.5 Sinopharm Group Zhonglian Pharmaceutical Recent Developments
  55. 8.10 Qilu Pharmaceutical
  56. 8.10.1 Qilu Pharmaceutical Company Information
  57. 8.10.2 Qilu Pharmaceutical Business Overview
  58. 8.10.3 Qilu Pharmaceutical Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qilu Pharmaceutical Hydroxyurea Tablets Product Portfolio
  60. 8.10.5 Qilu Pharmaceutical Recent Developments
  61. 8.11 Shandong Anxin Pharmaceutical
  62. 8.11.1 Shandong Anxin Pharmaceutical Company Information
  63. 8.11.2 Shandong Anxin Pharmaceutical Business Overview
  64. 8.11.3 Shandong Anxin Pharmaceutical Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shandong Anxin Pharmaceutical Hydroxyurea Tablets Product Portfolio
  66. 8.11.5 Shandong Anxin Pharmaceutical Recent Developments
  67. 8.12 Shanxi Zhendong Anxin Biopharmaceutical
  68. 8.12.1 Shanxi Zhendong Anxin Biopharmaceutical Company Information
  69. 8.12.2 Shanxi Zhendong Anxin Biopharmaceutical Business Overview
  70. 8.12.3 Shanxi Zhendong Anxin Biopharmaceutical Hydroxyurea Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shanxi Zhendong Anxin Biopharmaceutical Hydroxyurea Tablets Product Portfolio
  72. 8.12.5 Shanxi Zhendong Anxin Biopharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxyurea Tablets Value Chain Analysis
  2. 9.1.1 Hydroxyurea Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxyurea Tablets Production Mode & Process
  6. 9.2 Hydroxyurea Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxyurea Tablets Distributors
  9. 9.2.3 Hydroxyurea Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst